Lymphocytic choriomeningitis virus expands a population of NKG2D+CD8+ T cells that exacerbates disease in mice coinfected with Leishmania major

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3301-3310

  Crosby, Erika J ^a   Clark, Megan ^a   Novais, Fernanda O ^a   Wherry, E John ^b   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR NKG2D; CYTOKINE; GRANZYME; GZMB PROTEIN, MOUSE; KLRK1 PROTEIN, MOUSE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; LEISHMANIASIS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MIXED INFECTION; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; LEISHMANIA MAJOR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METABOLISM; MICROBIOLOGY; PARASITOLOGY; SKIN LEISHMANIASIS; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COINFECTION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GRANZYMES; INFLAMMATION; INTERFERON-GAMMA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGES; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84942474081     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500855     Document Type: Article

References (44)

1. Stelekati, E., and E. J. Wherry. 2012. Chronic bystander infections and immunity to unrelated antigens. Cell Host Microbe 12: 458-469.
2. Alvar, J., I. D. Vélez, C. Bern, M. Herrero, P. Desjeux, J. Cano, J. Jannin, and M. den Boer, WHO Leishmaniasis Control Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671.
3. Kaye, P., and P. Scott. 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 9: 604-615.
4. O'Neal, S. E., L. H. Guimarães, P. R. Machado, L. Alcantara, D. J. Morgan, S. Passos, M. J. Glesby, and E. M. Carvalho. 2007. Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J. Infect. Dis. 195: 142-148.
5. La Flamme, A. C., P. Scott, and E. J. Pearce. 2002. Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol. 24: 339-345.
6. Santiago, H. C., M. A. Oliveira, E. A. Bambirra, A. M. Faria, L. C. Afonso, L. Q. Vieira, and R. T. Gazzinelli. 1999. Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation, and parasitism in BALB/c mice infected with Leishmania major. Infect. Immun. 67: 4939-4944.
7. Crosby, E. J., M. H. Goldschmidt, E. J. Wherry, and P. Scott. 2014. Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. PLoS Pathog. 10: e1003970.
8. Valentine, L., R. Potts, and M. Premenko-Lanier. 2012. CD8+ T cell-derived IFN-g prevents infection by a second heterologous virus. J. Immunol. 189: 5841-5848.
9. Hogan, L. H., D. O. Co, J. Karman, E. Heninger, M. Suresh, and M. Sandor. 2007. Virally activated CD8 T cells home to Mycobacterium bovis BCG-induced granulomas but enhance antimycobacterial protection only in immunodeficient mice. Infect. Immun. 75: 1154-1166.
10. Edwards, M. J., O. Buchatska, M. Ashton, M. Montoya, Q. D. Bickle, and P. Borrow. 2005. Reciprocal immunomodulation in a schistosome and hepatotropic virus coinfection model. J. Immunol. 175: 6275-6285.
11. Gonzalez-Lombana, C., C. Gimblet, O. Bacellar, W. W. Oliveira, S. Passos, L. P. Carvalho, M. Goldschmidt, E. M. Carvalho, and P. Scott. 2013. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog. 9: e1003243.
12. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168: 1675-1684.
13. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-1147.
14. Späth, G. F., and S. M. Beverley. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99: 97-103.
15. Afonso, L. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61: 2952-2959.
16. Lutz, M. B., N. Kukutsch, A. L. J. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
17. León, B., M. López-Bravo, and C. Ardavín. 2007. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26: 519-531.
18. Goncalves, R., X. Zhang, H. Cohen, A. Debrabant, and D. M. Mosser. 2011. Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J. Exp. Med. 208: 1253-1265.
19. Novais, F. O., B. T. Nguyen, D. P. Beiting, L. P. Carvalho, N. D. Glennie, S. Passos, E. M. Carvalho, and P. Scott. 2014. Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J. Infect. Dis. 209: 1288-1296.
20. Zinkernagel, R. M., and H. Hengartner. 1992. Virally induced immunosuppression. Curr. Opin. Immunol. 4: 408-412.
21. Novais, F. O., and P. Scott. 2015. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Semin. Immunopathol. 37: 251-259.
22. Novais, F. O., L. P. Carvalho, J. W. Graff, D. P. Beiting, G. Ruthel, D. S. Roos, M. R. Betts, M. H. Goldschmidt, M. E. Wilson, C. I. de Oliveira, and P. Scott. 2013. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog. 9: e1003504.
23. Santos, Cda. S., V. Boaventura, C. Ribeiro Cardoso, N. Tavares, M. J. Lordelo, A. Noronha, J. Costa, V. M. Borges, C. I. de Oliveira, J. Van Weyenbergh, et al. 2013. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNg(+)-mediated parasite killing in human cutaneous leishmaniasis. J. Invest. Dermatol. 133: 1533-1540.
24. Brodskyn, C. I., A. Barral, V. Boaventura, E. Carvalho, and M. Barral-Netto. 1997. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J. Immunol. 159: 4467-4473.
25. Faria, D. R., P. E. Souza, F. V. Durães, E. M. Carvalho, K. J. Gollob, P. R. Machado, and W. O. Dutra. 2009. Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol. 31: 432-439.
26. Jamieson, A. M., A. Diefenbach, C. W. McMahon, N. Xiong, J. R. Carlyle, and D. H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19-29.
27. Ehrlich, L. I., K. Ogasawara, J. A. Hamerman, R. Takaki, A. Zingoni, J. P. Allison, and L. L. Lanier. 2005. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. J. Immunol. 174: 1922-1931.
28. Markiewicz, M. A., L. N. Carayannopoulos, O. V. Naidenko, K. Matsui, W. R. Burack, E. L. Wise, D. H. Fremont, P. M. Allen, W. M. Yokoyama, M. Colonna, and A. S. Shaw. 2005. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J. Immunol. 175: 2825-2833.
29. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
30. Osborne, L. C., L. A. Monticelli, T. J. Nice, T. E. Sutherland, M. C. Siracusa, M. R. Hepworth, V. T. Tomov, D. Kobuley, S. V. Tran, K. Bittinger, et al. 2014. Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science 345: 578-582.
31. Reese, T. A., B. S. Wakeman, H. S. Choi, M. M. Hufford, S. C. Huang, X. Zhang, M. D. Buck, A. Jezewski, A. Kambal, C. Y. Liu, et al. 2014. Coinfection. Helminth infection reactivates latent g-herpesvirus via cytokine competition at a viral promoter. Science 345: 573-577.
32. Santos, D. M., M. W. Carneiro, T. R. de Moura, M. Soto, N. F. Luz, D. B. Prates, J. M. Irache, C. Brodskyn, A. Barral, M. Barral-Netto, et al. 2013. PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania. Nanomedicine (Lond.) 9: 985-995.
33. Belkaid, Y., E. Von Stebut, S. Mendez, R. Lira, E. Caler, S. Bertholet, M. C. Udey, and D. Sacks. 2002. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168: 3992-4000.
34. Novais, F. O., L. P. Carvalho, S. Passos, D. S. Roos, E. M. Carvalho, P. Scott, and D. P. Beiting. 2015. Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology. J. Invest. Dermatol. 135: 94-101.
35. Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13: 159-175.
36. Leist, T. P., E. Rüedi, and R. M. Zinkernagel. 1988. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells. J. Exp. Med. 167: 1749-1754.
37. Borrow, P., C. F. Evans, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69: 1059-1070.
38. Ivashkiv, L. B., and L. T. Donlin. 2014. Regulation of type I interferon responses. Nat. Rev. Immunol. 14: 36-49.
39. Marshall, H. D., S. L. Urban, and R. M. Welsh. 2011. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85: 5929-5939.
40. Wilson, E. B., D. H. Yamada, H. Elsaesser, J. Herskovitz, J. Deng, G. Cheng, B. J. Aronow, C. L. Karp, and D. G. Brooks. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340: 202-207.
41. Teijaro, J. R., C. Ng, A. M. Lee, B. M. Sullivan, K. C. Sheehan, M. Welch, R. D. Schreiber, J. C. de la Torre, and M. B. Oldstone. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340: 207-211.
42. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745.
43. Mueller, S. N., K. A. Hosiawa-Meagher, B. T. Konieczny, B. M. Sullivan, M. F. Bachmann, R. M. Locksley, R. Ahmed, and M. Matloubian. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317: 670-674.
44. Soudja, S. M., A. L. Ruiz, J. C. Marie, and G. Lauvau. 2012. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37: 549-562.